TABLE 1.

Clinical characteristics of volunteers

Treatment group and subject no.	Age (yr)	CD4 T-cell count (cells/μl)	CD4 nadir	HAART (mo)	HLA alleles
					A and B	DRB1
MVA/HIVA only
011	37	650	240	19	A30, 74 B*5802/06	DRB1*15, *11
012	34	720	140	62	A1, 3 B7, 8	DRB1*03, *13
013	41	600	100	50	A*0201, 1 B8, 18	DRB1*03, *04
014	48	380	200	12	A*03, 11 B42, 53	DRB1*15, *1001
015	32	390	10	61	A*0201, 3 B*2705, 53	DRB1*1001, *1302
016	44	310	160	42	A2 B18, B*0710	DRB1*04
018	25	430	200	17	A24, *3401 B40, 56	DRB1*04, *11
019	25	670	230	19	A2, 24 B35, 57	DRB1*08
021	58	420	240	12	A1, *0201 B8, 44	DRB1*13, *11
022	38	300	160	19	A29, 30 B57, 18	DRB1*11, *13
MVA.HIVA 2 yrs after pTHr.HIVA
001	48	810	240	67	A2, *03 B35, *44	DRB1*13
002	50	770	20	98	A*0102, *33 B*44, *5802	DRB1*12, *13
004	54	800	40	77	A1, *03 B35, 37	DRB1*01, *15
005	44	460	170	55	A2, 29 B*45, *5802	DRB1*12, *13
006	34	520	10	90	A2 B15, *44	DRB1*04
007	35	540	190	51	A*0201, 03 B*35, *44	DRB1*01, *07
009	40	700	180	100	A3, 11 B7	DRB1*15
010	41	510	140	38	A*01, 1 B18, 35	DRB1*03, *09